BED BATH & BEYOND, INC. 8-K

What Happened

• Bed Bath & Beyond, Inc. announced that at its 2026 annual meeting stockholders approved a Charter Amendment to increase the number of authorized shares of common stock from 100,000,000 to 200,000,000. The company filed the Certificate of Amendment with the Delaware Secretary of State on May 14, 2026, and it became effective upon filing.
• At the same meeting, stockholders also approved an amendment and restatement of the company’s Amended and Restated 2005 Equity Incentive Plan (the “Restated Plan”), which adds 4,291,000 newly authorized shares for issuance under the plan, plus additional shares available through the plan’s amended share‑recycling provisions.
• The Form 8‑K (filed May 19, 2026) attaches the Certificate of Amendment as Exhibit 3.1 and incorporates the Restated Plan as Exhibit 10.1. Item 5.02 (departure/election of directors or officers) is referenced in the filing but no additional officer/director details are provided in the body of this 8‑K.

Key Details

• Authorized common shares increased from 100,000,000 to 200,000,000 shares.
• Certificate of Amendment filed with Delaware on May 14, 2026; effective upon filing.
• Equity Incentive Plan increase: 4,291,000 newly authorized shares plus recycled shares under amended provisions.
• Exhibits: Certificate of Amendment (Exhibit 3.1) and Amended & Restated 2005 Equity Incentive Plan (Exhibit 10.1) are filed with the 8‑K.

Why It Matters

• Doubling authorized shares creates capacity for future stock issuances (e.g., financing, acquisitions, or equity compensation). The filing itself does not announce any specific issuance, but it enables the company to sell or grant additional common stock if the board decides to do so.
• The approved equity plan increase and revised recycling rules mean the company can grant more stock-based awards to employees and executives, which can dilute existing shareholders if and when awards are issued and shares are delivered.
• Investors should note the potential for future dilution and watch for subsequent filings (e.g., registration statements, Form 4s, press releases) that would disclose any actual share issuances or grant activity stemming from these approvals.